Improper dosing of compounded drugs was identified as a concern for the FDA in an alert released in July
Are there risks to blood pressure when starting GLP-1 therapy
The risks fall into three buckets Common, mild, self-limiting Bruising or soreness at the catheter site Cool sensation along the arm during the drip Warm flush or metallic taste, especially with magnesium or B-complex Mild lightheadedness if the drip runs too fast Uncommon Phlebitis, or vein irritation, especially with stronger or more concentrated formulas Infiltration (fluid leaking under the skin if the catheter shifts) Allergic reactions to specific ingredients, particularly thiamine and B-complex Rare but serious Infection at the IV site Fluid overload in patients with heart, kidney, or liver disease Electrolyte disturbances, especially with high-dose magnesium, potassium, or calcium Red blood cell problems in people with G6PD deficiency, a genetic enzyme issue
Fact : According to FDA, a compounded drug might be appropriate if a patients medical need cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available
Double-check the serving size
